loxoprofen has been researched along with Bone Loss, Perimenopausal in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the first case of pseudogout attack in the distal interphalangeal (DIP) joints during etidronate disodium therapy." | 1.33 | Pseudogout attack induced during etidronate disodium therapy. ( Anayama, S; Maekawa, S; Nakajima, I; Sato, E; Sugiyama, H; Watanabe, H; Yamada, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, H | 1 |
| Yamada, S | 1 |
| Anayama, S | 1 |
| Sato, E | 1 |
| Maekawa, S | 1 |
| Sugiyama, H | 1 |
| Nakajima, I | 1 |
1 other study available for loxoprofen and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Pseudogout attack induced during etidronate disodium therapy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Chondrocalcinosis; Etidro | 2006 |